[1] [3] The mechanism of action of semaglutide involves binding to GLP-1 receptors found throughout the body, particularly in the pancreas, gastrointestinal tract, and brain
Am J Physiol Endocrinol Metab 294(5):E846E852 Chedid V, Vijayvargiya P, Carlson P, Van Malderen K, Acosta A, Zinsmeister A et al (2018) Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: a pilot pharmacogenetics study
Two key enzymes are implicated in PUFA-PE synthesis, including acyl-CoA synthetase long-chain family member 4 (ACSL4) and lysophosphatidylcholine acyltransferase 3 (LPCAT3) [75]
The guideline advances a new approach to risk assessment through a novel risk score, sets lower low-density lipoprotein cholesterol (LDL-C) and nonhigh-density lipoprotein cholesterol (HDL-C) treatment goals for patients with established atherosclerotic cardiovascular disease (ASCVD), and recommends measuring lipoprotein(a) [Lp(a)] at least once to identify individuals at higher risk of ASCVD.The guideline dissemination tools include a Central Illustration to graphically convey key concepts, as well as tables highlighting updates in the ACC/AHA/Multisociety Dyslipidemia Guideline and comparisons to the 2025 European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) Focused Update of the 2019 Guidelines for the Management of Dyslipidaemias